Skip to content
InsiderLens
Feed
Screener
MCP
Methodology
⌘K
EN
Pricing
Sign in
Feed
Screener
MCP
Methodology
EN
English
Español
Français
Pricing
Sign in
Liminatus Pharma, Inc. (LIMN) — insider trading: 0 buys, 0 sells · InsiderLens
/
/
Liminatus Pharma, Inc.
Liminatus Pharma, Inc.
LIMN
Insider trading at Liminatus Pharma, Inc.
Transactions on record
2
since Jul 6, 2026
Insider buys
0
Insider sells
0
Active insiders · 12 months
1
last filing Jul 14, 2026
Figures computed from official regulatory filings —
.
Insiders on record at Liminatus Pharma, Inc.
Choi Beom Kyu
Chief Technology Officer
Dam Scott
Chief Financial Officer
Kim Chris
Chief Executive Officer
· Director
· 10% owner
Lee Sang-Jin
Head of Research & Development
Yoo Byong Chul
Chief Science Officer
Baek Ji Yeon
Director
Baek Richard JaiHwan
Director
Fernandez Nicholas
Director
Lee Eun Sook
Director
Lemons II Philip Wayne
Director
Ewon Comfortech Co., Ltd.
10% owner
Iris Acquisition Holdings LLC
10% owner
KH Feelux Co., Ltd
10% owner
Valetudo Therapeutics LLC
10% owner
Home
Companies
methodology
Insider transaction history at Liminatus Pharma, Inc.
Latest
Largest
Insider
Filed
Type
Qty
Price
Value · USD
Src
Details
Valetudo Therapeutics LLC
Jul 14, 2026
Other
3,448,926
—
—
SEC
Valetudo Therapeutics LLC
Jul 6, 2026
Other
-4,373,603
—
—
SEC